Features & Specs
- Anti-MMAE/DXD antibodies and anti-idiotypic antibodies;
- High specificity & affinity;
- High sensitivity & stability;
- Positive reference of ADCs preclinical / clinical immunogenicity.
Already a member? Login here
By creating an account you agree to our Terms and Conditions, Terms of Use, and Privacy Policy and you understand that by downloading vendor information you are agreeing to share your contact information with that vendor.
The activity of anti-MMAE monoclonal antibody (Cat.No.MME-M5252) is verified by binding to Disitamab Vedotin (RC-48) with a linear range of 0.1-2 ng/mL.